Skip to content

Insider · CIK 0001824161

Mark S. Livingston

cfoofficer

Files at PGNY (Progyny, Inc.). First filing Nov 19, 2025, latest Jun 5, 2026.

In brief

Mark S. Livingston files SEC Form 4 as CFO at PGNY (Progyny, Inc.). Since Nov 19, 2025, Mark S. Livingston has reported 0 open-market buys worth $0 and 6 open-market sells worth $843k, the latest filed on Jun 5, 2026.

A track record needs three past buys with six months of prices behind them; Mark S. Livingston has 0, so none is measured yet.

The newest scored trade: sold $64k of PGNY on Jun 4, 2026, filed Jun 5, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 6 sells worth $843k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $843k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PGNY: Progyny, Inc.

PGNYOct 9, 2026 · close 27.93

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
25Weak
PGNYsell 510b5-1
Progyny, Inc.
$64k
2,517 shares
-3%+56% from low-10% from high
17Weak
PGNYsell 610b5-1
Progyny, Inc.
$7,310
279 shares
-0%+54% from low-12% from high
29Weak
PGNYsell 610b5-1
Progyny, Inc.
$211k
8,275 shares
-9%+57% from low-10% from high
10Weak
PGNYsell 210b5-1
Progyny, Inc.
$12k
459 shares
-1%+83% from low-3% from high
10Weak
PGNYsell 210b5-1
Progyny, Inc.
$5,432
213 shares
-0%+76% from low-7% from high
39Weak
PGNYsell 210b5-1
Progyny, Inc.
$543k
21,303 shares
-31%+96% from low0% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 4, 2026 PGNY
Progyny, Inc.
2,517
0.00% of outstanding
$64kJun 4, 2026$218k
Jun 2, 2026 PGNY
Progyny, Inc.
279
0.00% of outstanding
$7,310Jun 2, 2026$211k
May 20, 2026 PGNY
Progyny, Inc.
8,275
0.01% of outstanding
$211kMay 20, 2026none
Dec 11, 2025 PGNY
Progyny, Inc.
459
0.00% of outstanding
$12kDec 11, 2025$549k
Dec 2, 2025 PGNY
Progyny, Inc.
213
0.00% of outstanding
$5,432Dec 2, 2025$543k
Nov 17, 2025 PGNY
Progyny, Inc.
21,303
0.02% of outstanding
$543kNov 17, 2025none
Dec 1, 2023 PGNY
Progyny, Inc.
25,087
0.03% of outstanding
$869kDec 1, 2023none

Transactions

Every row this insider has filed, 26 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 4, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-479$26.61$13k72,45335 d ago
Sep 2, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-224$25.66$5,74874,46439 d ago
Sep 3, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-1,532$26.29$40k72,93239 d ago
Jun 3, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock10b5-1
-1,082$25.12$27k77,544Jun 5, 2026
Jun 4, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock10b5-1
-339$24.99$8,47277,205Jun 5, 2026
Jun 4, 2026PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-1,918$25.50$49k75,287Jun 5, 2026
Jun 4, 2026PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-599$25.50$15k74,688Jun 5, 2026
Jun 2, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock10b5-1
-158$26.20$4,14078,905Jun 3, 2026
Jun 2, 2026PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-279$26.20$7,31078,626Jun 3, 2026
May 20, 2026PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-8,275$25.50$211k79,063May 21, 2026
Mar 4, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-339$17.52$5,93987,338Mar 6, 2026
Mar 2, 2026PGNY
Progyny, Inc.
AGrant or award
Common Stock
+45,454$0.00$092,437Mar 4, 2026
Mar 2, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-181$17.69$3,20292,256Mar 4, 2026
Mar 3, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-4,579$17.60$81k87,677Mar 4, 2026
Mar 2, 2026PGNY
Progyny, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+66,289$0.00$066,289Mar 4, 2026
Dec 11, 2025PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-459$25.50$12k46,983Dec 15, 2025
Dec 4, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-479$24.55$12k47,442Dec 8, 2025
Dec 2, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock10b5-1
-224$25.27$5,66048,134Dec 4, 2025
Dec 2, 2025PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-213$25.50$5,43247,921Dec 4, 2025
Nov 17, 2025PGNY
Progyny, Inc.
SOpen-market sale
Common Stock10b5-1
-21,303$25.50$543k48,358Nov 19, 2025
Sep 4, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-479$23.54$11k69,661Sep 5, 2025
Sep 2, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-2,032$23.67$48k70,140Sep 3, 2025
Jun 4, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-339$21.98$7,45172,172Jun 5, 2025
Jun 2, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-1,848$21.50$40k72,511Jun 3, 2025
Dec 2, 2024PGNY
Progyny, Inc.
FTax withholding
Common Stock
-2,617$15.57$41k41,596Dec 4, 2024
Nov 26, 2024PGNY
Progyny, Inc.
FTax withholding
Common Stock
-224$15.75$3,52844,213Nov 27, 2024

Questions about Mark S. Livingston

Answered from the filings on this page, as of the latest one.

Is Mark S. Livingston buying or selling?

In the last 12 months Mark S. Livingston reported 0 open-market buys worth $0 and 6 open-market sells worth $843k on SEC Form 4; the latest was sold $64k of PGNY on Jun 4, 2026. Grants, option exercises and tax withholding are not counted.

How did Mark S. Livingston's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark S. Livingston has 0.

Where does Mark S. Livingston file Form 4?

Mark S. Livingston has filed Form 4 at PGNY (Progyny, Inc.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark S. Livingston: insider trades and track record | InsiderTell